SIRT6 and atherosclerosis: Because most of SIRT6 knockout mice die at 4 weeks of age [11], we used SIRT6 heterozygous (SIRT6+/−) mice to study whether SIRT6 haploin-sufficiency affects endothelium-dependent vasorelaxation and atherosclerosis.